FLGT (STOCKS)
Fulgent Genetics, Inc. Common Stock
$23.000000
-0.060000 (-0.26%)
Prev close: $23.060000
Company Information
- Exchange
- XNAS
- Sector
- Health Services
- Industry
- Medical/Nursing Services
- CEO
- Ming Hsieh
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $710.99M
- Employees
- 1,313
- P/E (TTM)
- -16.45
- P/B (TTM)
- 0.63
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $315.55M |
| Benefits Costs and Expenses | $364.35M |
| Cost Of Revenue | $185.41M |
| Costs And Expenses | $364.35M |
| Gross Profit | $130.14M |
| Nonoperating Income/Loss | $22.20M |
| Operating Expenses | $201.14M |
| Research and Development | $51.85M |
| Other Operating Expenses | $149.29M |
| Operating Income/Loss | -$70.99M |
| Income/Loss From Continuing Operations After Tax | -$44.17M |
| Income/Loss From Continuing Operations Before Tax | -$48.80M |
| Income Tax Expense/Benefit | -$4.63M |
| Income Tax Expense/Benefit, Deferred | -$1.47M |
| Net Income/Loss | -$44.17M |
| Net Income/Loss Attributable To Noncontrolling Interest | -$1.19M |
| Net Income/Loss Attributable To Parent | -$42.98M |
| Net Income/Loss Available To Common Stockholders, Basic | -$42.98M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Average Shares | 30,848,000 |
| Diluted Average Shares | 30,848,000 |
| Assets | $1.21B |
| Current Assets | $507.37M |
| Prepaid Expenses | $6.31M |
| Other Current Assets | $501.06M |
| Noncurrent Assets | $707.19M |
| Fixed Assets | $111.87M |
| Intangible Assets | $135.26M |
| Other Non-current Assets | $460.07M |
| Liabilities | $93.81M |
| Current Liabilities | $72.43M |
| Accounts Payable | $18.09M |
| Other Current Liabilities | $54.34M |
| Noncurrent Liabilities | $21.38M |
| Equity | $1.12B |
| Equity Attributable To Noncontrolling Interest | -$5.13M |
| Equity Attributable To Parent | $1.13B |
| Liabilities And Equity | $1.21B |
| Net Cash Flow From Operating Activities | $1.52M |
| Net Cash Flow From Operating Activities, Continuing | $1.52M |
| Net Cash Flow From Investing Activities | $72.76M |
| Net Cash Flow From Investing Activities, Continuing | $72.76M |
| Net Cash Flow From Financing Activities | -$14.58M |
| Net Cash Flow From Financing Activities, Continuing | -$14.58M |
| Exchange Gains/Losses | -$104.00K |
| Net Cash Flow | $59.60M |
| Net Cash Flow, Continuing | $59.70M |
| Comprehensive Income/Loss | -$46.92M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | -$1.58M |
| Comprehensive Income/Loss Attributable To Parent | -$45.34M |
| Other Comprehensive Income/Loss | -$2.75M |